Peptide antibiotics

US11279733B2 · kind B2 · utility

Assignee

• The University Of Queensland · AU

Inventors

• Matthew Cooper · Cambridge, GB
• Mark Arnold Thomas Blaskovich · Brisbane, AU
• Alejandra Gallardo-Godoy · Brisbane, AU
• Karl Hansford · Brisbane, AU
• Alysha Elliott · Brisbane, AU
• Craig Muldoon · Faulconbridge, AU
• Bernd Becker · Bad Endbach, DE

Key dates

• Filing date: Nov 2, 2018
• Grant date: Mar 22, 2022
• Expiry date: Nov 2, 2038

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

There is provided a range of novel compounds. These novel compounds may demonstrate abroad spectrum antibacterial and antifungal activity. These compounds may be active against the emerging polymyxin resistant bacteria. These compounds may also be useful when used in conjunction with other pharmaceutically active agents.